Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Perseus Mining Increases Share Buy-Back from AUD100M to AUD 150M
-
Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress
-
Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026
-
Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026
-
Author Fari Presents Cambodia's Path to Peace and Stability in New Book on Hun Sen's Leadership
-
Author Fari Presents Cambodia's Path to Peace and Stability in New Book on Hun Sen's Leadership
-
Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control
-
Modat adds Passive DNS to its Platform Magnify, Connecting Every Signal in a Single Investigation Graph
-
Orbs Launches On-Chain Execution Infrastructure for Institutional Crypto Trading
-
Modat adds Passive DNS to its Platform Magnify, Connecting Every Signal in a Single Investigation Graph
-
Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual
-
Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at E
-
Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026)
-
Bitcoin Meets AI Trading: AIXAlpha Launches Free AI Strategy Contracts with Daily Settlement
-
Over 100 Organizations Thank America’s Blood Donors on World Blood Donor Day
-
Ruvi AI (RUVI) Announces Phase 3 Has Reached 90% Sellout as Investors Race to Secure Remaining Tokens at $0.02
-
MUSSO E80 Muse Sees Strong U.S. Sales Following European Breakout and MUSE Design Award Win
-
Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor (NEXPOVIO®) Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
-
Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting
-
Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
-
KFSH Highlights Human-Centered AI as a Path to Better Care at HLTH Europe 2026
-
Salomon Unfolds the Next Chapter of ROAD TO THE FUTURE in Shanghai
-
KFSH Showcases Trusted AI as the Foundation for Scalable Healthcare Transformation at HLTH Europe 2026
-
Ripple’s XRP Meets AI Trading: AIXAlpha Launches Free AI Strategy Contracts with Daily Settlement
-
Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease
-
Don't Pay Full Price for Power: WattCycle's Prime Day Event Drops Up to 70% Off LiFePO4 Batteries Starting June 15
-
Don't Pay Full Price for Power: WattCycle's Prime Day Event Drops Up to 70% Off LiFePO4 Batteries Starting June 15
-
Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026
-
Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
-
FREELANDER 8 Makes First Public Appearance Ahead of Official Abu Dhabi Launch
-
Hitch Open Ping-Pong Embodied (HOPE) AI Challenge Joins the 2026 World Humanoid Robot Games, Seeding Advanced Physical AI Against Human Performance
-
Defiance ETFs Announces Temporary Trading Halt of the Defiance Daily 2X Space ETF (SPCL) on Cboe BZX Exchange, Inc.
-
Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
-
Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1
-
Crypto News Today: AlphaPepe Unveils AlphaSwap Early Access as Bitcoin Price Prediction Eyes $250,000
-
Ops+AI and Arrowhead Strategy Group Announce Strategic Partnership to Help Founders Build Smarter, Stronger, More Scalable Companies
-
ROMA Green Finance Establishes Dedicated Artificial Intelligence and High-Performance Computing Infrastructure Investment Vertical
-
HAMANASI ADVENTURE & DIVE RESORT, BELIZE RANKED #1 HOTEL IN CENTRAL AMERICA AND #15 IN THE WORLD IN 2026 TRIPADVISOR TRAVELERS’ CHOICE BEST OF THE BEST AWARDS
-
HAMANASI ADVENTURE & DIVE RESORT, BELIZE RANKED #1 HOTEL IN CENTRAL AMERICA AND #15 IN THE WORLD IN 2026 TRIPADVISOR TRAVELERS’ CHOICE BEST OF THE BEST AWARDS
-
Rio Silver Announces Results of Annual General Meeting
-
Prime Drink Group Announces Private Placement and Agreed Resolution with Creditors
-
CORRECTION -- Leverage Shares by Themes Launches 2X Long and -2X Short SpaceX ETFs with 0.75% Fee to Meet Unprecedented Retail Demand
-
Julian Barnes Named Laureate of the 2026 Fitzgerald Prize
-
Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes
-
Gencor Releases Second Quarter Fiscal 2026 Results
-
Heartland Express, Inc. Declares Regular Quarterly Dividend
-
Traws Pharma Provides Regulatory Update on Influenza Program
-
Following White House Small Business Summit, SBA and GSA Take Action to Prioritize American-Made Products in Federal Purchasing
-
Cushing crude stocks sit less than 2 mmbbls above operational floor amid global supply crisis
-
Rocket Doctor Grants Stock Options and RSUs
